89bio Inc (ETNB) SEC News Oct. 30, 2025, 12:58 UTC 1 0 comments New Form SC 14D9/A - 89bio, Inc. Filed: 2025-10-30 AccNo: 0001193125-25-257605 Size: 18 KB Comment Full text
Cardinal Health Inc (CAH) SEC News Oct. 30, 2025, 12:49 UTC 1 0 comments New Form 10-Q - CARDINAL HEALTH INC Filed: 2025-10-30 AccNo: 0000721371-25-000130 Size: 8 MB Comment Full text
Arcus Biosciences Inc. (RCUS) SEC News Oct. 30, 2025, 12:49 UTC 1 1 comments Jaen Juan C. 🔴 sold 96.9K shares of Arcus Biosciences, Inc. (RCUS) at $22.04 ($2.0M) Transaction Date: Oct 28, 2025 | Filing ID: 000005 Comment Full text
89bio Inc (ETNB) SEC News Oct. 30, 2025, 12:48 UTC 1 0 comments New Form SC TO-T/A - 89bio, Inc. Filed: 2025-10-30 AccNo: 0001193125-25-257567 Size: 55 KB Comment Full text
Neogen Corporation (NEOG) SEC News Oct. 30, 2025, 12:47 UTC 3 1 comments (76% Positive) Neogen Corporation (NEOG) Files Form 8-K Comment Full text
ABVC BioPharma Inc. (ABVC) SEC News Oct. 30, 2025, 12:31 UTC 3 1 comments (99% Neutral) ABVC BIOPHARMA, INC. (ABVC) Announces Executive Changes Comment Full text
Ultragenyx Pharmaceutical Inc (RARE) SEC News Oct. 30, 2025, 12:30 UTC 3 1 comments (75% Positive) Ultragenyx Pharmaceutical Inc. (RARE) Announces Clinical Development Update Comment Full text
Alnylam Pharmaceuticals Inc (ALNY) SEC News Oct. 30, 2025, 12:17 UTC 3 0 comments New Form 10-Q - ALNYLAM PHARMACEUTICALS, INC. Filed: 2025-10-30 AccNo: 0001628280-25-047345 Size: 10 MB Comment Full text
Evaxion Biotech A/S (EVAX) SEC News Oct. 30, 2025, 12:15 UTC 3 1 comments (99% Neutral) Evaxion Biotech A/S (EVAX) Announces Clinical Development Update (Form 6-K) Comment Full text
GSK plc (GLAXF) SEC News Oct. 30, 2025, 12:12 UTC 3 1 comments (99% Neutral) GSK plc (GLAXF) Files Form 6-K Comment Full text